Esperion Therapeutics Stock Volatility Indicators Average True Range

ESPR Stock

USD 2.52 -0.07 -2.70%

Use the volatility indicators workspace to apply Average True Range indicator and other studies to Esperion Therapeutics. This view tracks volatility indicators and range-based signals to support structured performance interpretation without implying advice.Enter Time Period to generate the indicator output.

Symbol

The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Esperion Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Esperion Therapeutics Technical Analysis Modules

Most technical analysis of Esperion Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Esperion from various momentum indicators to cycle indicators. When you analyze Esperion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

About Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. A high-level view of Esperion Therapeutics emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 98.42, profit margin of -5.63%. Esperion Therapeutics has a market cap of 619.17 M, ROE of -2.61%.

Methodology

Unless otherwise specified, financial data for Esperion Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Esperion (USA Stocks:ESPR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Esperion Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Esperion Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Esperion Stock is Curated By:

Ellen Johnson · Member of Macroaxis Editorial Board

Become your own money manager

Tracking Esperion Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Latest Portfolios Now

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	FinTech Invested over 20 shares	Go
	Momentum Invested over 40 shares	Go
	Baby Boomer Prospects Invested over 60 shares	Go
	Impulse Invested over 200 shares	Go
	Cash Cows Invested few shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Marketing Invested few shares	Go
	Investor Favorites Invested over 20 shares	Go
	Driverless Cars Invested few shares	Go

Additional Tools for Esperion Stock Analysis

	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC